YJ Generics has developed a new business model responsive to an accelerating trend in the peptide industry: developing and manufacturing research-grade peptides and related compounds under strict cGMP standards at the lowest possible cost for biotech companies. Since our formation in Stockholm, Sweden over seven years ago, we have lead the industry and become a staple manufacturing partner for peptide projects. From pre-clinical and clinical to commercial peptides, YJG can accommodate your company's needs. Please allow us to introduce APi's capabilities.
With multiple manufacturing suites in the United States and Sweden, YJG has the ability to produce peptide APIs at gram to kilogram scale by solid phase synthesis, solution phase synthesis, or hybrid solid/solution phase synthesis. YJG has validated a dedicated manufacturing line for a generic peptide API at kilogram scale scheduled for re-validation and commercial manufacturing at 150-200 kg/year scale (25-50kg batches). We invite you to view our catalog of products or contact us to speak to a customer service representative.
Unlike most peptide manufacturers, YJG realizes that the majority of research and discovery projects only call for small quantities of product. Allow us to produce GLP-grade peptides for your pre-clinical applications prior to paying for GMP-grade peptides for your commerical use. Each customer at YJG is treated equally, with every project having just as much attention and importance regardless of size and scale. Let us help your projects progress through the stages of development and onto the market without breaking the bank.